Addressing Stigma

According to the American Psychiatric Association, fear of stigma can lead patients to forego getting treatment, leading to poor health outcomes. These resources focus on understanding and addressing the stigma of opioid use disorder and treatment to ensure that patients have the medications and support they need.

  • New England Journal of Medicine. Perspective: Controlling the Swing of the Opioid Pendulum (Feb 2018). This perspective piece provides a case example of a patient who is negatively impacted by a clinic’s decision to implement a no-opioid policy, which means they would no longer prescribe any opioids. This piece goes into the reasons such policies exist and recommendations on how to overcome challenges which may result in clinics choosing to implement no-opioid policies.
  • New England Journal of Medicine. Perspective: Caring for Ms. L. — Overcoming My Fear of Treating Opioid Use Disorder (Feb 2018). This perspective piece provides a case example of a patient who had come to a physician asking for buprenorphine treatment which is used to treat substance use disorders. The physician did not go through the training to get the licensure for buprenorphine treatment due to several reasons, including stigma that was associated with treating patients with substance use disorders. This piece provides insight into this physician going through the licensure process and experiencing providing treatment to patients in need.
  • The Role of Shame in Opioid Use Disorders. (2016) Shame plays an important role in opioid use disorders (OUD) and can impede treatment if not addressed appropriately. In this module, participants will learn to recognize and appropriately address shame in patients with OUD. Participants will learn about particular groups of people with OUD who have specific concerns regarding shame, including people who inject heroin, and opioid-addicted pregnant women and mothers. In addition, treatment options that address shame in people with OUD are outlined. CME credit available.
  • Follow-up Q and A Webinar: The Role of Shame in Opioid Use Disorders. (2016) This Q and A webinar further discussed Dr. Braun-Gabelman’s online module, “The Role of Shame in Opioid Use Disorders,” with questions from participants and a few cases related to this topic. CME credit available.
  • Addiction, Stigma, and Discrimination: Implications for Treatment and Recovery. (2015) This presentation outlines the background and significance of stigma in relation to addictive disorders, highlights how stigma influences treatment access and treatment and recovery outcomes, and discusses what can be done to address and reduce stigma to enhance the quality of addiction care. CME credit available.
  • Stigma in Methadone and Buprenorphine Maintenance Treatment. (2015) This module describes the history of methadone maintenance and the effectiveness and key myths of opioid agonist treatment. The module explores empathizing with patients taking methadone or buprenorphine and empowering clinicians to support patients and their significant others. CME credit available.
  • SAMHSA Proposed Rule: Confidentiality of Substance Use Disorder Records. (April 5, 2016): The Substance Abuse and Mental Health Services Administration (SAMHSA) issued on February 9 proposed changes to the confidentiality rule for substance use disorder records to facilitate health information exchange while protecting patient privacy. “This proposal will help patients with substance use disorders fully participate and benefit from a health care delivery system that’s better, smarter and healthier, while protecting their privacy,” said Health and Human Services Secretary Sylvia Burwell. SAMHSA will accept comments on the proposed rule through April 11.

Case Examples

Related Resources

Advisory
Public
Sign In to Download the Regulatory Advisory: Medicare Physician Fee Schedule: Proposed Rule for CY 2021 The Centers for Medicare & Medicaid Services (…
Webinar Recordings
State Association
View Webinar.
Case Studies
Public
To meet the demand for health care workforce development and expansion, New York’s Staten Island Performing Provider System (SI PPS) partnered with the College…
Letter/Comment
Public
The AHA recognizes that SAMHSA is statutorily constrained in making structural amendments to the regulations under 42 CFR Part 2; however, because the proposed…
Letter/Comment
Public
The AHA appreciates the opportunity to comment on the Drug Enforcement Administration’s proposed notice on aggregate production quotas for schedule I and II…
Webinar Recordings
Member
HELD SEPTEMBER 24 The AHA's Section for Psychiatric & Substance Abuse Services and AHA’s Physician Alliance on September 24, 2019 held a webinar on…